Skip to main navigation Skip to search Skip to main content

Valoració d'un algoritme multimodal per al tractament de la incontinència fecal en dones residents a la comunitat: Avaluació de l'eficàcia sobre l'impacte en la severitat clínica i la qualitat de vida, i sobre la fisiopatologia subjacents a la qual es dirigeix

Student thesis: Doctoral thesis

Abstract

Introduction: Fecal incontinence (FI) is a debilitating condition that severely impacts patients' quality of life (QoL). This thesis is based on three consecutive studies that assess the pathophysiology, treatments according to stool consistency, and the effects of rehabilitation treatments in women with FI, highlighting clinical severity and QoL. Scientific rationale: Stool consistency plays a key role in the severity of FI. The pathophysiology of patients with loose stools is associated with higher disease severity and poorer QoL, particularly in the dimensions of lifestyle, coping, and depression. Hypotheses and objectives: The general hypothesis is that stool consistency and its improvement through targeted treatments influence the clinical severity and QoL of patients with FI. The objectives are: To assess the impact of loose stools on clinical severity and QoL. To study the effect of specific treatments to improve stool consistency. To evaluate the efficacy of a multimodal algorithm based on pathophysiology. Study design: The three studies include observational and quasi-experimental approaches, focusing on the relationship between stool consistency and FI severity, as well as the efficacy of treatments. Timeframe: Cross-sectional and prospective studies. Comparison: The studies analyze stool consistency (Bristol ≥5 vs <5) and treatments aimed at patients with loose stools. Laboratory: Clinical study with human patients. International registration: Approved by the Ethics Committee (16/19). Sample size calculation: Conducted using Granmo v7. 11. Single-center: Hospital de Mataró. Results: Approximately 50% of patients presented with loose stools (Bristol ≥5), associated with higher clinical severity (St. Mark's) and poorer QoL. Patients treated with cholestyramine showed significant improvement in stool consistency and a reduction in FI severity. Patients with normal stools (Bristol <5) treated with techniques such as biofeedback and neuromodulation showed improvements in both clinical severity and QoL. Conclusions: The studies demonstrate that improving stool consistency significantly reduces FI severity and enhances QoL, validating the need for personalized interventions based on each patient's pathophysiology. Long-term follow-up is necessary to evaluate the sustainability of these benefits.
Date of Award7 Apr 2025
Original languageCatalan
SupervisorLluís Mundet i Pons (Director) & Pedro Clave Civit (Director)

Cite this

'